Final Results of the IFCT-0803 Study, a Phase II Study of Cetuximab, Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced, Unresectable, Stage III, Non-Squamous, Non-Small-cell Lung Cancer.
Cancer/Radiothérapie(2022)
关键词
Stage III NSCLC,Concurrent chemoradiotherapy,Cetuximab,Pemetrexed,Cisplatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要